Trial NCT03317496

View at ClinicalTrials.gov 
Org. Study IDs: B9991023
Secondary IDs: 2017-001741-27 B9991023 JAVELIN CHEMOTHERAPY MEDLEY

Last trial update was posted on 2023-08-29

MeSH Interventions

Antibodies, Monoclonal Avelumab Carboplatin Cisplatin Gemcitabine Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

Non-small Cell Lung Cancer Urothelial Cancer

Stopping Reasons

The study was terminated since there was no need for further safety or efficacy data to be collected. The participants having benefit from the investigational treatments have been moved to a continuation study (NCT05059522).

Limitations And Caveats

The study was terminated since there was no need for further safety or efficacy data to be collected. The subjects having benefit from the investigational treatments have been moved to a continuation study NCT05059522

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID